Autonomix medical, inc. reports second quarter fiscal year 2025 financial results and provides a corporate update

Ongoing proof-of-concept (poc) clinical trial in pain associated with pancreatic cancer; preliminary results demonstrate 100% of the lead-in patient responder group went to zero opioid use at 4-6 weeks post-procedure
AMIX Ratings Summary
AMIX Quant Ranking